| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.0M | — |
| R&D Expense | $12.3M | -11.6% |
| SG&A Expense | $6.7M | -52.4% |
| Operating Income | -$9.3M | +66.8% |
| Income Tax | $0 | — |
| Net Income | -$3.6M | +87.7% |
| EPS (Basic) | -$0.11 | +92.1% |
| EPS (Diluted) | -$0.11 | +92.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | -50.9% |
| Short-term Investments | $0 | — |
| Current Assets | $9.1M | -50.1% |
| Total Assets | $10.1M | -48.1% |
| Current Liabilities | $10.2M | -54.5% |
| Stockholders' Equity | -$809K | +88.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.7M | +114.0% |
| Capital Expenditures | $17K | +0.0% |
| Investing Cash Flow | -$17K | +0.0% |
| Financing Cash Flow | -$12.5M | -163.7% |
| Free Cash Flow | $3.7M | +113.9% |